Daniella Beckman - 08 Dec 2021 Form 4/A - Amendment Insider Report for Blueprint Medicines Corp (BPMC)

Role
Director
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
08 Dec 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
31 Mar 2022, 16:05:33 UTC
Date Of Original Report
10 Dec 2021
Previous filing
14 Sep 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Award $0 +3,400 $0.000000 3,400 08 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Award $0 +7,000 $0.000000 7,000 08 Dec 2021 Common Stock 7,000 $98.72 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved the Reporting Person's receipt of a grant of 3,400 restricted stock units in accordance with the Issuer's non-employee director compensation policy.
F2 This option vests with respect to 1/36th of the shares underlying the option on January 8, 2022 and as to an additional 1/36th of the shares underlying the option each month thereafter.

Remarks:

This Form 4 is being amended to correct the Reporting Owner, which was incorrect in the original report due to the use of erroneous filer codes, and is otherwise unchanged.